SYK Operating Cash Flow
$5.53BTTM · USD
Period ending:
SYK FY Operating Cash FlowUSD
$5.04B$0.00
1989-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SYK operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 5,044,000,000 | |
| 4,242,000,000 | |
| 3,711,000,000 | |
| 2,624,000,000 | |
| 3,263,000,000 | |
| 3,277,000,000 | |
| 2,191,000,000 | |
| 2,610,000,000 | |
| 1,559,000,000 | |
| 1,915,000,000 | |
| 899,000,000 | |
| 1,782,000,000 | |
| 1,886,000,000 | |
| 1,657,000,000 | |
| 1,434,000,000 | |
| 1,547,400,000 | |
| 1,460,700,000 | |
| 1,175,900,000 | |
| 1,028,300,000 | |
| 867,300,000 | |
| 863,800,000 | |
| 593,300,000 | |
| 648,500,000 | |
| 503,900,000 | |
| 468,300,000 | |
| 331,800,000 | |
| 284,000,000 | |
| 154,500,000 | |
| 91,900,000 | |
| 204,300,000 | |
| 111,500,000 | |
| 97,700,000 | |
| 86,100,000 | |
| 50,700,000 | |
| 37,600,000 | |
| 48,300,000 | |
| 21,500,000 |
Compare operating cash flow
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) operating cash flow
- Johnson & Johnson (JNJ) operating cash flow
- AbbVie (ABBV) operating cash flow
- UnitedHealth Group (UNH) operating cash flow
- Merck & Co. (MRK) operating cash flow
- Thermo Fisher Scientific (TMO) operating cash flow
- Amgen (AMGN) operating cash flow
- Gilead Sciences (GILD) operating cash flow
All SYK financial metrics · SYK stock overview · How to interpret financial metrics
